BGM · BGM Group Ltd.
Market Cap
$110.04M
Shares
13.35M
Volume · Oct 21
1243
Avg daily vol (14 sessions)
9667
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$8.24
Open$8.24
Day$8.22–8.24
52W close$7.20–296.55
Avg vol 30d6K
Short int4K · 0.0% float · 1.5d
Short vol10%
DataJan 2021–Oct 2026
Metrics snapshot
Useful current figures from the complete screener profile.
Revenue (TTM)
—
Trailing 12 months
Net income (TTM)
—
Trailing 12 months
Revenue growth YoY
+51.1%
Year over year
Operating margin
-33.2%
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
—
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
+1,467.3%
Year over year · more shares
Price change (1Y)
—
Trailing year
Short interest
0.0%
Latest settlement · 1.5 days to cover
Equibles Rating
blended score · not investment adviceOverall
Sell
SellHoldBuy
Technical
Sell
Momentum
Weak
Sentiment
Bearish
Fundamentals
Strong
Quant / Vol
Very High
Market backdrop
VIX 17.3 · elevated
Equity put/call 0.56
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−65%
below
Price vs 50-day avg
−2%
below
RSI (14)
45
neutral
MACD trend
Negative
52-week position
0%
near low
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
+6%
trailing
6-month return
−8%
trailing
YTD return
−93%
this year
Relative strength
−16%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $8 › 200d $23 — 200d above 50d
Institutional flow
Distributing
-14% holders QoQ · +3 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
0.03% of float · ▲ +86.0% MoM · 1.5 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
12 holders — mid 2-yr range
Squeeze score
32
low risk · 0–100
Fundamentals
Revenue growth
+51%
Y/Y
Gross margin
17%
expanding
EPS growth
+10%
Y/Y
Free cash flow
$-3.9M
Quant / Vol
risk profile
Volatility
123%
annualized · 1-yr
Max drawdown
−98%
past year
ATR
12.5%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Sell
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−65%
Bearish
Price vs 50-day avg
−2%
Neutral
RSI (14)
45
Neutral
MACD trend
Negative
Bearish
52-week position
0%
Bearish
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
Bearish · 2 of 6
Trend (MA cross)
No cross
50d $8 › 200d $23 — 200d above 50d
Institutional flow
Distributing
-14% holders QoQ · +3 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
0.03% of float · ▲ +86.0% MoM · 1.5 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
12 holders — mid 2-yr range
Price context
position in its 52-week range
Range low $7
Now $8 · 0%
Range high $297
vs 200-day avg -65%
vs 50-day avg -2%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Drug Manufacturers - Specialty & Generic — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
BGM
this stock
BGM Group Ltd.
|
$110.04M | — | +51.1% | — | 0.0% |
|
TAK
Takeda Pharmaceutical Co Ltd
|
$64.15B | +27.8% | — | — | 0.1% |
|
GALDY
Galderma Group AG
|
$48.88B | +2.4% | — | — | 0.0% |
|
TEVA
Teva Pharmaceutical Industries Ltd
|
$46.21B | +30.2% | +4.3% | 65.0 | 2.6% |
|
HLN
Haleon plc
|
$44.72B | -0.9% | — | — | 0.6% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Institutional Holders
Accumulating
Holders
12
- % held
- 0.1%
- Net QoQ
- +5.6K sh
- Top holder
- GEODE CAPITAL MANAGEMENT,…
Held
Float
Short & Settlement
Financials
Filings
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| BGM | -21.4% | +6.5% | -8.4% | +9.0% | -92.6% |
| SPY | +0.5% | +0.7% | +7.6% | +1.4% | +13.4% |
| vs SPY | -21.8% | +5.8% | -16.0% | +7.6% | -105.9% |
Capital returns
Latest dividend
$7.50
/ share · ex Feb 27, 2023
Paid (TTM)
$0.00
/ share · 0 payouts
Dividend yield (TTM, derived)
— · no payout in the trailing year
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.